The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of a real-time updated evidence library in addressing lag in guideline updates to aide physicians.
 
David Spigel
Leadership - ASCO (Inst)
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Circle Pharma (Inst); Daiichi Sankyo (Inst); Gatorade Company (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Jazz Pharmaceuticals (Inst); Medpace (Inst); ModeX Therapeutics (Inst); OncoScope (Inst); Ottimo Pharma (Inst); Pfizer (Inst); Pyxis (Inst)
Research Funding - Abbvie (Inst); Agios (Inst); Arcus Biosciences (Inst); Ascendis Pharma (Inst); Asher Biotherapeutics (Inst); AstraZeneca (Inst); BeiGene (Inst); Beijing Avistone Biotechnology (Inst); Bicara Therapeutics (Inst); BioAtla (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Chugai Pharma (Inst); cyteir (Inst); Ellipses Pharma (Inst); Erasca, Inc (Inst); Foundation Bio (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); GRAIL (Inst); Janux Therapeutics (Inst); Jazz Pharmaceuticals (Inst); Kronos Bio (Inst); Kumquat Biosciences (Inst); Loxo (Inst); Lyell Immunopharma (Inst); Macrogenics (Inst); Merck (Inst); Millennium (Inst); Moderna Therapeutics (Inst); Molecular Templates (Inst); Monte Rosa Therapeutics (Inst); NGM Biopharmaceuticals (Inst); Peloton Therapeutics (Inst); Phanes Therapeutics (Inst); Pierre Fabre (Inst); ProfoundBio (Inst); PureTech (Inst); Razor Genomics (Inst); Repare Therapeutics (Inst); Rgenix (Inst); Scorpion Therapeutics (Inst); Shenzhen Chipscreen Biosciences (Inst); Stemline Therapeutics (Inst); Synthekine (Inst); Taiho Oncology (Inst); Tango Therapeutics (Inst); Zai Lab (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Genentech; Novartis
 
Saro Sarkisian MD
No Relationships to Disclose
 
Douglas Flora
Employment - IntegraConnect; St. Elizabeth Healthcare
Stock and Other Ownership Interests - Azra AI
Honoraria - bristol myers squibb; MiBA
Consulting or Advisory Role - Aeon Therapeutics; Azra AI; PatientPoint; Reimagine Care; SAGA Diagnostics; VieCure
Speakers' Bureau - Bristol Myers Squibb
 
Stacy Grieve
No Relationships to Disclose
 
Anna Forsythe
No Relationships to Disclose
 
Jessicca Rege
No Relationships to Disclose
 
Rhiannon Campden
No Relationships to Disclose
 
Rozee Liu
No Relationships to Disclose
 
Robert Coleman
Employment - US Oncology; Vaniam Group
Stock and Other Ownership Interests - McKesson/US Oncology Network
Consulting or Advisory Role - Abbvie; Alkermes; Alkermes; AstraZeneca/MedImmune; Clovis Oncology; Eisai; Genentech/Roche; Genmab; GlaxoSmithKline; GOG Foundation; Gradalis; Immunogen; Karyopharm Therapeutics; Merck; Merck
Research Funding - Alkermes; AstraZeneca/MedImmune; Immunogen (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck; Pfizer (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Clovis Oncology; GOG Foundation; Merck; Research to Practice; Roche/Genentech; Sotio; Vaniam Group